Evaluation of feasibility phase of adaptive version of locally made bubble continuous positive airway pressure oxygen therapy for the treatment of COVID-19 positive and negative adults with severe pneumonia and hypoxaemia
Mohammod Jobayer Chisti, Ahmed Ehsanur Rahman, Taufiq Hasan, Tahmeed Ahmed, Shams El Arifeen, John David Clemens, Abu Sayem Mirza Md Hasibur Rahman, Md Fakhar Uddin, Md Robed Amin, Md Titu Miah, Md Khairul Islam, Mohiuddin Sharif, Abu Sadat Mohammad Sayeem Bin Shahid, Anisuddin Ahmed, Goutom Banik, Meemnur Rashid, Md Kawsar Ahmed, Lubaba Shahrin, Farzana Afroze, Monira Sarmin, Sharika Nuzhat, Supriya Sarkar, Jahurul Islam, Muhammad Shariful Islam, John Norrie, Harry Campbell, Harish Nair, Steve Cunningham
Journal of Global Health
Background: Bubble continuous positive airway pressure (bCPAP) oxygen therapy has been shown to be safe and effective in treating children with severe pneumonia and hypoxaemia in Bangladesh. Due to lack of adequate non-invasive ventilatory support during coronavirus disease 2019 (COVID-19) crisis, we aimed to evaluate whether bCPAP was safe and feasible when adapted for use in adults with similar indications. Methods: Adults (18-64 years) with severe pneumonia and moderate hypoxaemia (80 to <90% oxygen saturation (SpO2) in room air) were provided bCPAP via nasal cannula at a flow rate of 10 litres per minute (l/min) oxygen at 10 centimetres (cm) H2O pressure, in two tertiary hospitals in Dhaka, Bangladesh. Qualitative interviews and focus group discussions, using a descriptive phenomenological approach, were performed with patients and staff (n = 39) prior to and after the introduction (n = 12 and n = 27 respectively) to understand the operational challenges to the introduction of bCPAP. Results: We enrolled 30 adults (median age 52, interquartile range (IQR) 40-60 years) with severe pneumonia and hypoxaemia and/or acute respiratory distress syndrome (ARDS) irrespective of coronavirus disease 2019 (COVID-19) test results to receive bCPAP. At baseline mean SpO2 on room air was 87% (±2) which increased to 98% (±2), after initiation of bCPAP. The mean duration of bCPAP oxygen therapy was 14.4 ± 24.8 hours. There were no adverse events of note, and no treatment failure or deaths. Operational challenges to the clinical introduction of bCPAP were lack of functioning pulse oximeters, difficult nasal interface fixation among those wearing nose pin, occasional auto bubbling or lack of bubbling in water-filled plastic bottle, lack of holder for water-filled plastic bottle, rapid turnover of trained clinicians at the hospitals, and limited routine care of patients by hospital clinicians particularly after official hours. Discussion: If the tertiary hospitals in Bangladesh are supplied with well-functioning good quality pulse oximeters and enhanced training of the doctors and nurses on proper use of adapted version of bCPAP, in treating adults with severe pneumonia and hypoxaemia with or without ARDS, the bCPAP was found to be safe, well tolerated and not associated with treatment failure across all study participants. These observations increase the confidence level of the investigators to consider a future efficacy trial of adaptive bCPAP oxygen therapy compared to WHO standard low flow oxygen therapy in such patients. Conclusion: s Although bCPAP oxygen therapy was found to be safe and feasible in this pilot study, several challenges were identified that need to be taken into account when planning a definitive clinical trial.Bubble continuous positive airway pressure (bCPAP) oxygen therapy has been shown to be safe and effective in treating children with severe pneumonia and hypoxaemia in Bangladesh. Due to lack of adequate non-invasive ventilatory support during coronavirus disease 2019 (COVID-19) crisis, we aimed to evaluate whether bCPAP was safe and feasible when adapted for use in adults with similar indications. Methods Adults (18-64 years) with severe pneumonia and moderate hypoxaemia (80 to <90% oxygen saturation (SpO2) in room air) were provided bCPAP via nasal cannula at a flow rate of 10 litres per minute (l/min) oxygen at 10 centimetres (cm) H2O pressure, in two tertiary hospitals in Dhaka, Bangladesh. Qualitative interviews and focus group discussions, using a descriptive phenomenological approach, were performed with patients and staff (n = 39) prior to and after the introduction (n = 12 and n = 27 respectively) to understand the operational challenges to the introduction of bCPAP. Results We enrolled 30 adults (median age 52, interquartile range (IQR) 40-60 years) with severe pneumonia and hypoxaemia and/or acute respiratory distress syndrome (ARDS) irrespective of coronavirus disease 2019 (COVID-19) test results to receive bCPAP. At baseline mean SpO2 on room air was 87% (±2) which increased to 98% (±2), after initiation of bCPAP. The mean duration of bCPAP oxygen therapy was 14.4 ± 24.8 hours. There were no adverse events of note, and no treatment failure or deaths. Operational challenges to the clinical introduction of bCPAP were lack of functioning pulse oximeters, difficult nasal interface fixation among those wearing nose pin, occasional auto bubbling or lack of bubbling in water-filled plastic bottle, lack of holder for water-filled plastic bottle, rapid turnover of trained clinicians at the hospitals, and limited routine care of patients by hospital clinicians particularly after official hours. Discussion If the tertiary hospitals in Bangladesh are supplied with well-functioning good quality pulse oximeters and enhanced training of the doctors and nurses on proper use of adapted version of bCPAP, in treating adults with severe pneumonia and hypoxaemia with or without ARDS, the bCPAP was found to be safe, well tolerated and not associated with treatment failure across all study participants. These observations increase the confidence level of the investigators to consider a future efficacy trial of adaptive bCPAP oxygen therapy compared to WHO standard low flow oxygen therapy in such patients. Conclusion s Although bCPAP oxygen therapy was found to be safe and feasible in this pilot study, several challenges were identified that need to be taken into account when planning a definitive clinical trial.
COVID-19 Severity Prediction from Chest X-ray Images Using an Anatomy-Aware Deep Learning Model
Nusrat Binta Nizam, Sadi Mohammad Siddiquee, Mahbuba Shirin, Mohammed Imamul Hassan Bhuiyan, Taufiq Hasan
Journal of Digital Imaging
The COVID-19 pandemic has been adversely affecting the patient management systems in hospitals around the world. Radiological imaging, especially chest x-ray and lung Computed Tomography (CT) scans, plays a vital role in the severity analysis of hospitalized COVID-19 patients. However, with an increasing number of patients and a lack of skilled radiologists, automated assessment of COVID-19 severity using medical image analysis has become increasingly important. Chest x-ray (CXR) imaging plays a significant role in assessing the severity of pneumonia, especially in low-resource hospitals, and is the most frequently used diagnostic imaging in the world. Previous methods that automatically predict the severity of COVID-19 pneumonia mainly focus on feature pooling from pre-trained CXR models without explicitly considering the underlying human anatomical attributes. This paper proposes an anatomy-aware (AA) deep learning model that learns the generic features from x-ray images considering the underlying anatomical information. Utilizing a pre-trained model and lung segmentation masks, the model generates a feature vector including disease-level features and lung involvement scores. We have used four different open-source datasets, along with an in-house annotated test set for training and evaluation of the proposed method. The proposed method improves the geographical extent score by 11% in terms of mean squared error (MSE) while preserving the benchmark result in lung opacity score. The results demonstrate the effectiveness of the proposed AA model in COVID-19 severity prediction from chest X-ray images. The algorithm can be used in low-resource setting hospitals for COVID-19 severity prediction, especially where there is a lack of skilled radiologists.
Comparison of Low-cost, Electricity-free, CPAP (OXYJET) with High-Flow Nasal Cannula Treatment outside Critical Care: A Randomized Clinical Trial
Taufiq Hasan, Md Kawsar Ahmed, Kaisar Ahmed Alman, Meemnur Rashid, Farhan Muhib, Saeedur Rahman, Nawsabah Noor, Md Khairul Islam, Forhad Uddin Hasan Chowdhury, Md Mohiuddin Sharif, Rifat Hossain Ratul, Sohana Jahan, Md Titu Miah, Robed Amin, Alain Bernard Labrique, Yasser Khan
Background: In Low- and Middle-income Countries (LMICs), the general wards typically are limited to providing low-flow oxygen therapy (up to 15L/min). However, high-flow treatment, such as noninvasive ventilation (NIV) administered in pre-ICU settings, has effectively reduced intensive care unit (ICU) admissions. Here, we describe a low-cost, electricity-free, pressure-driven, and 3D-printed continuous positive airway pressure (CPAP) device (‘OxyJet’) which can provide noninvasive ventilation support in the general wards. This study assesses whether the developed CPAP device can be alternative to a HighFlow Nasal Cannula (HFNC) device for supporting hypoxemic patient outside critical care. Methods: We performed an open-label, parallel-assignment, randomized controlled trial in 45 severely hypoxemic patients, between April 17 to July 9, 2021 (NCT04681859). The primary outcome was ventilator-free days at day 10 (VFD10). We compared changes from baseline in peripheral oxygen saturation, heart rate, respiratory rate, mortality hazard-ratio, death/intubation in 10 days, patient recovery, adverse events and oxygen consumption of the two treatment groups. Results: The trial results showed that the patients in CPAP group had a mean difference in the ventilatorfree days at day 10 (VFD10) of 2.75 (95% CI -0.17—5.68; p=0.003). The mortality of the patients in CPAP group showed a low hazard-ratio (HR) of 0.65 (95% CI 0.31—1.37; p=0.041). The death/intubation in 10 days of the patients in CPAP group showed a low relative-risk (RR) of 0.52 (95% CI 0.25—1.05; p=0.033). Finally, the device consumed significantly less oxygen than HFNC, with a median difference of -16.11 L/min (95% CI -24.63 — -6.67; p=0.001).
An end-to-end deep learning framework for real-time denoising of heart sounds for cardiac disease detection in unseen noise
Shams Nafisa Ali, Samiul Based Shuvo, Muhammad Ishtiaque Sayeed Al-Manzo, Anwarul Hasan, Taufiq Hasan
IEEE Access, vol. 11
The heart sound signals captured via a digital stethoscope are often distorted by environmental and physiological noise, altering their salient and critical properties. The problem is exacerbated in crowded low-resource hospital settings with high noise levels which degrades the diagnostic performance. In this study, we present a novel deep encoder-decoder-based denoising architecture (LU-Net) to suppress ambient and internal lung sound noises. Training is done using a large benchmark PCG dataset mixed with physiological noise, i.e., breathing sounds. Two different noisy datasets were prepared for experimental evaluation by mixing unseen lung sounds and hospital ambient noises with the clean heart sound recordings. We also used the inherently noisy portion of the PASCAL heart sound dataset for evaluation. The proposed framework showed effective suppression of background noises in both unseen real-world data and synthetically generated noisy heart sound recordings, improving the signal-to-noise ratio (SNR) level by 5.575 dB on an average using only 1.32 M parameters. The proposed model outperforms the current state-of-the-art U-Net model with an average SNR improvement of 5.613 dB and 5.537 dB in the presence of lung sound and unseen hospital noise, respectively. LU-Net also outperformed the state-of-the-art Fully Convolutional Network (FCN) by 1.750 dB and 1.748 dB for lung sound and unseen hospital noise conditions, respectively. In addition, the proposed denoising method model improves classification accuracy by 38.93% in the noisy portion of the PASCAL heart sound dataset. The results presented in the paper indicate that our proposed architecture demonstrated a robust denoising performance on different datasets with diverse levels and characteristics of noise. The proposed deep learning-based PCG denoising approach is a pioneering study that can significantly improve the accuracy of computer-aided auscultation systems for detecting cardiac diseases in noisy, low-resource hospitals and underserved communities.
Activity Classification from First-Person Office Videos with Visual Privacy Protection
Partho Ghosh, Md Abrar Istiak, Nayeeb Rashid, Ahsan Habib Akash, Ridwan Abrar, Ankan Ghosh Dastider, Asif Shahriyar Sushmit, Taufiq Hasan
Proceedings of International Conference on Fourth Industrial Revolution and Beyond 2021
With the advent of wearable body cameras, human activity classification from First-Person Videos (FPV) has become a topic of increasing importance for various applications, including life-logging, law enforcement, sports, workplace, and health care. One of the challenging aspects of FPV is its exposure to potentially sensitive objects within the user’s field of view. In this work, we developed a visual privacy-aware activity classification system focusing on office videos. We utilized a Mask R-CNN with an Inception-ResNet hybrid as a feature extractor for detecting and later blurring out sensitive objects (e.g., digital screens, human face, paper) from the videos. We incorporate an ensemble of Recurrent Neural Networks (RNNs) with ResNet, ResNeXt, and DenseNet-based feature extractors for activity classification. The proposed system was trained and evaluated on the FPV office video dataset which is a subset of the BON [1] vision dataset for office activity recognition (2021) and includes 18 classes made available through the IEEE Video and Image Processing (VIP) Cup 2019 competition. On the original unprotected FPVs, the proposed activity classifier ensemble reached an accuracy of 85.078% with precision, recall, and F1 scores of 0.88, 0.85, and 0.86, respectively. The performances were slightly degraded on privacy-protected videos, with accuracy, precision, recall, and F1 scores at 73.68%, 0.79, 0.75, and 0.74, respectively.
Learning to generalize towards unseen domains via a content-aware style invariant framework for disease detection from chest x-rays
Mohammad Zunaed, M Haque, Taufiq Hasan
IEEE Journal of Biomedical and Health Informatics
Performance degradation due to distribution discrepancy is a longstanding challenge in intelligent imaging, particularly for chest X-rays (CXRs). Recent studies have demonstrated that CNNs are biased toward styles (e.g., uninformative textures) rather than content (e.g., shape), in stark contrast to the human vision system. Radiologists tend to learn visual cues from CXRs and thus perform well across multiple domains. Motivated by this, we employ the novel on-the-fly style randomization modules at both image (SRM-IL) and feature (SRM-FL) levels to create rich style perturbed features while keeping the content intact for robust cross-domain performance. Previous methods simulate unseen domains by constructing new styles via interpolation or swapping styles from existing data, limiting them to available source domains during training. However, SRM-IL samples the style statistics from the possible value range of a CXR image instead of the training data to achieve more diversified augmentations. Moreover, we utilize pixel-wise learnable parameters in the SRM-FL compared to pre-defined channel-wise mean and standard deviations as style embeddings for capturing more representative style features. Additionally, we leverage consistency regularizations on global semantic features and predictive distributions from with and without style-perturbed versions of the same CXR to tweak the model's sensitivity toward content markers for accurate predictions. Our proposed method, trained on CheXpert and MIMIC-CXR datasets, achieves 77.32\pm0.35, 88.38\pm0.19, 82.63\pm0.13 AUCs(%) on the unseen domain test datasets, i.e., BRAX, VinDr-CXR, and NIH chest X-ray14, respectively, compared to 75.56\pm0.80, 87.57\pm0.46, 82.07\pm0.19 from state-of-the-art models on five-fold cross-validation with statistically significant results in thoracic disease classification.
ThoraX-PriorNet: A novel attention-based architecture using anatomical prior probability maps for thoracic disease classification
Md Iqbal Hossain, Mohammad Zunaed, Md Kawsar Ahmed, SM Jawwad Hossain, Anwarul Hasan, Taufiq Hasan
IEEE Access, vol. 12
Computer-aided disease diagnosis and prognosis based on medical images is a rapidly emerging field. Many Convolutional Neural Network (CNN) architectures have been developed by researchers for disease classification and localization from chest X-ray images. It is known that different thoracic disease lesions are more likely to occur in specific anatomical regions compared to others. This article aims to incorporate this disease and region-dependent prior probability distribution within a deep learning framework. We present the ThoraX-PriorNet, a novel attention-based CNN model for thoracic disease classification. We first estimate a disease-dependent spatial probability, i.e., an anatomical prior, that indicates the probability of occurrence of a disease in a specific region in a chest X-ray image. Next, we develop a novel attention-based classification model that combines information from the estimated anatomical prior and automatically extracted chest region of interest (ROI) masks to provide attention to the feature maps generated from a deep convolution network. Unlike previous works that utilize various self-attention mechanisms, the proposed method leverages the extracted chest ROI masks along with the probabilistic anatomical prior information, which selects the region of interest for different diseases to provide attention. The proposed method shows superior performance in disease classification on the NIH ChestX-ray14 dataset compared to existing state-of-the-art methods while reaching an area under the ROC curve (%AUC) of 84.67. Regarding disease localization, the anatomy prior attention method shows competitive performance compared to state-of-the-art methods, achieving an accuracy of 0.80, 0.63, 0.49, 0.33, 0.28, 0.21, and 0.04 with an Intersection over Union (IoU) threshold of 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, and 0.7, respectively. The proposed ThoraX-PriorNet can be generalized to different medical image classification and localization tasks where the probability of occurrence of the lesion is dependent on specific anatomical sites.